|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 21.98 USD | -4.60% |
|
-5.46% | +40.18% |
| 06-29 | Monte Rosa Therapeutics, Inc.(NasdaqGS:GLUE) added to Russell 2500 Growth Benchmark | CI |
| 06-29 | Monte Rosa Therapeutics, Inc.(NasdaqGS:GLUE) dropped from Russell Microcap Value Benchmark Index | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -4.60% | -5.46% | +20.54% | +25.24% | +40.18% | +325.97% | +206.56% | +18.24% | - | 1.95B | |
| +0.44% | +1.41% | +20.05% | +13.85% | +9.45% | +4.36% | +10.81% | -12.02% | +250.57% | 50.73B | |
| -1.57% | -3.18% | +19.55% | +34.96% | +130.95% | +383.82% | +593.37% | +480.10% | - | 39.73B | |
| -0.14% | +0.77% | +14.38% | +20.68% | -7.92% | +27.49% | -5.50% | -16.86% | +192.08% | 34.69B | |
| +1.76% | -1.78% | +14.93% | -0.55% | +0.05% | +21.44% | +53.38% | -7.99% | +921.71% | 33.21B | |
| -0.06% | -0.45% | +1.21% | -5.81% | +1.58% | +2.94% | +28.70% | -19.02% | +149.43% | 26.76B | |
| -1.93% | -1.01% | +21.63% | - | - | - | - | - | - | 16.8B | |
| -1.49% | -6.18% | +13.45% | +5.78% | -5.60% | +63.89% | +120.53% | +188.92% | - | 15.37B | |
| +0.78% | +1.16% | +8.46% | +7.09% | +11.38% | +14.69% | +17.32% | -31.76% | +104.41% | 13.78B | |
| -0.97% | -2.83% | +13.63% | +50.49% | -8.85% | +10.35% | -33.29% | -20.91% | +132.73% | 12.85B | |
| -2.28% | -6.83% | +41.21% | +14.60% | -0.25% | +1,589.17% | +646.89% | +314.14% | +2,971.61% | 12.11B | |
| -1.57% | -0.73% | +22.53% | +28.83% | +15.17% | +44.13% | +9.84% | -40.03% | +170.42% | 11.24B | |
| +0.08% | +0.62% | +32.15% | +24.04% | +21.34% | +31.81% | -15.49% | -37.05% | +149.66% | 11.11B | |
| -3.95% | -7.86% | +16.96% | +21.64% | -5.28% | -1.67% | - | - | - | 10.46B | |
| +0.13% | +0.24% | +51.50% | +54.28% | +77.29% | +250.87% | - | - | - | 10.02B | |
| -7.50% | -3.80% | +28.07% | +24.70% | +41.88% | +148.20% | +395.29% | +126.51% | - | 9.82B | |
| -2.58% | -31.77% | -22.55% | -24.28% | -28.26% | +35.99% | +33.03% | +56.08% | +129.94% | 9.63B | |
| -3.21% | +0.34% | +18.00% | -0.77% | +6.72% | +522.40% | +1,476.74% | +11.19% | - | 9.06B | |
| -0.13% | -5.93% | +17.14% | +53.69% | +85.38% | +71.30% | +72.84% | +112.23% | +8.38% | 8.66B | |
| -0.17% | +5.85% | +11.82% | -1.12% | -12.46% | -18.20% | -19.48% | -21.24% | +62.06% | 8.58B | |
| Average | -1.45% | -3.34% | +18.23% | +18.28% | +19.62% | +185.73% | +211.27% | +64.74% | +436.92% | 17.33B | |
| Weighted average by Cap. | -0.78% | -2.19% | +17.30% | +16.72% | +22.57% | +147.86% | +175.75% | +80.69% | +422.34% |
- Stock Market
- Stocks
- GLUE Stock
- Sector Monte Rosa Therapeutics, Inc.
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
